Expression and purification of platelet-derived growth factor and evaluation of its function in binding to fibrinogen

Document Type : Original Research

Authors

1 Tarbiat Modares university

2 Tarbiat Modares university phD Student

Abstract
Abstract

The wound healing process is a complex and dynamic process that involves many metabolic pathways. This process consists of three phases inflammation, cell proliferation, and tissue regeneration stages. Successful wound healing depends on careful regulation and coordination between the factors involved. Until recent years, the strategy of treating chronic wounds was limited to wound preparation, removal of necrotic tissue, and control of infection and inflammation, but recently the use of growth factors has been approved to accelerate the healing process and heal the wound. Human recombinant growth factor PDGF-BB is one of the first types of recombinant growth factors approved in treating diabetic wounds. Several studies have reported that PDGF is an important mediator in wound healing that helps to accelerate healing, improve inflammation, cell proliferation, angiogenesis, and tissue regeneration. In this study, the human PDGF-B gene sequence was inserted into the pET 21a (+) expression vector for cloning and then inserted under the T7 promoter for its expression in the E. coli shuffle host. Purification was done using a nickel agarose column and to check the activity of the purified protein, cell proliferation, migration, and interaction were checked. The results of this study showed that the dimer type of PDGF expressed and purified in the bacterial host, probably due to maintaining the correct folded structure, has both main activities, i.e., cell proliferation due to the active binding to the cell receptor, as well as the ability to bind to fibrinogen.

Keywords

Subjects


1. Vaidyanathan, L. (2021) ‘Growth factors in wound healing’, Biomedical and Pharmacology Journal, 14(3), 1469–1480.
2. Locatelli, L. et al. (2021) ‘Platelets in Wound Healing: What Happens in Space?’, Frontiers in Bioengineering and Biotechnology, 9, 1–11.
3. Jian, K. et al. (2022) ‘PDGF-BB-derived supramolecular hydrogel for promoting skin wound healing’, Journal of Nanobiotechnology, 20(1), 1–9.
4. Moore, C. A. (2017). Aptamer-based biosensor for platelet-derived growth factor-bb using fluorescence resonance energy transfer, Texas State University, San Marcos, Texas.
5. Lynch, S.E. et al. (1987) ‘Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors.’, Proceedings of the National Academy of Sciences of the United States of America, 84(21), 7696–7700.
6. Ghasemi, Y. et al. (2020) ‘Cloning, expression, and purification of human PDGF-BB gene in Escherichia coli: New approach in PDGF-BB protein production’, Gene Reports, 19, 100653.
7. Chen, P.H., Chen, X. and He, X. (2013) ‘Platelet-derived growth factors and their receptors: Structural and functional perspectives’, Biochimica et Biophysica Acta - Proteins and Proteomics, 1834(10),2176–2186.
8. Westermark, B. and Heldin, C.H. (1993) ‘Platelet-derived growth factor structure, function and implications in normal and malignant cell growth’, Acta Oncologica, 32(2), 101–105.
9. Martino, M.M. et al. (2014) ‘Matrix Enhance Tissue Healing’, Science, 343, 885–889.
10. Martino, M.M. and Hubbell, J.A. (2010) ‘The 12th–14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain’, The FASEB Journal, 24(12), 4711–4721.
11. Deptuła, M. et al. (2020) ‘Development of a Peptide Derived from Platelet-Derived Growth Factor (PDGF-BB) into a Potential Drug Candidate for the Treatment of Wounds’, Advances in Wound Care, 9(12), 657–675.
12. Zhang, Z. et al. (2021) ‘PDGF-BB/SA/Dex injectable hydrogels accelerate BMSC-mediated functional full thickness skin wound repair by promoting angiogenesis’, Journal of Materials Chemistry B, 9(31), 6176–6189.
13. Cooke, JW. et al. (2006) Effect of rhPDGF-BB delivery on mediators of periodontal wound repair. Tissue Eng;12(6):1441-50.
14. Zhang, M. et al. (2018) ‘The effects of platelet-derived growth factor-BB on bone marrow stromal cell-mediated vascularized bone regeneration’, Stem Cells International. 31; 3272098.
15. Meng, X. et al. (2018) ‘Oxidation Prevents HMGB1 Inhibition on PDGF-Induced Differentiation of Multipotent Vascular Stem Cells to Smooth Muscle Cells: A Possible Mechanism Linking Oxidative Stress to Atherosclerosis’, BioMed Research International, 23; 4019814.
16. Devare, S.G. et al. (1984) ‘Expression of the PDGF-related transforming protein of simian sarcoma virus in E. coli’, Cell, 36(1), 43–49.
17. Feng, M. et al. (2022) ‘ATF4 promotes brain vascular smooth muscle cells proliferation, invasion and migration by targeting miR-552-SKI axis’, PLoS ONE, 17(7 July), 1–14.
18. Liang, C.C., Park, A.Y. and Guan, J.L. (2007) ‘In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro’, Nature Protocols, 2(2), 329–333.
19. Chen, L. et al. (2021) ‘Inhibition of PDGF-BB reduces alkali-induced corneal neovascularization in mice’, Molecular Medicine Reports, 23(4),1–11.
20. Liu, S. et al. (2023) ‘Fetal bovine serum, an important factor affecting the reproducibility of cell experiments’, Scientific Reports, 13(1), 1–8.
21. Mogford, J.E. et al. (2009) ‘Fibrin sealant combined with fibroblasts and platelet-derived growth factor enhances wound healing in excisional wounds’, Wound Repair and Regeneration, 17(3), 405–410.